Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

625 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.
Semb AG, Ueland T, Aukrust P, Wareham NJ, Luben R, Gullestad L, Kastelein JJ, Khaw KT, Boekholdt SM. Semb AG, et al. Among authors: luben r. Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):975-80. doi: 10.1161/ATVBAHA.109.184101. Epub 2009 Mar 26. Arterioscler Thromb Vasc Biol. 2009. PMID: 19325145
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.
Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT. Boekholdt SM, et al. Among authors: luben r. Arterioscler Thromb Vasc Biol. 2004 Aug;24(8):1503-8. doi: 10.1161/01.ATV.0000134294.54422.2e. Epub 2004 Jun 3. Arterioscler Thromb Vasc Biol. 2004. PMID: 15178568
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
Boekholdt SM, Keller TT, Wareham NJ, Luben R, Bingham SA, Day NE, Sandhu MS, Jukema JW, Kastelein JJ, Hack CE, Khaw KT. Boekholdt SM, et al. Among authors: luben r. Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):839-46. doi: 10.1161/01.ATV.0000157933.19424.b7. Epub 2005 Feb 3. Arterioscler Thromb Vasc Biol. 2005. PMID: 15692105
Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study.
Rip J, Nierman MC, Wareham NJ, Luben R, Bingham SA, Day NE, van Miert JN, Hutten BA, Kastelein JJ, Kuivenhoven JA, Khaw KT, Boekholdt SM. Rip J, et al. Among authors: luben r. Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):637-42. doi: 10.1161/01.ATV.0000201038.47949.56. Epub 2005 Dec 22. Arterioscler Thromb Vasc Biol. 2006. PMID: 16373616
Circulating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: the EPIC-Norfolk study.
Mallat Z, Benessiano J, Simon T, Ederhy S, Sebella-Arguelles C, Cohen A, Huart V, Wareham NJ, Luben R, Khaw KT, Tedgui A, Boekholdt SM. Mallat Z, et al. Among authors: luben r. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1177-83. doi: 10.1161/ATVBAHA.107.139352. Epub 2007 Feb 15. Arterioscler Thromb Vasc Biol. 2007. PMID: 17303774
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
Boekholdt SM, Kuivenhoven JA, Wareham NJ, Peters RJ, Jukema JW, Luben R, Bingham SA, Day NE, Kastelein JJ, Khaw KT. Boekholdt SM, et al. Among authors: luben r. Circulation. 2004 Sep 14;110(11):1418-23. doi: 10.1161/01.CIR.0000141730.65972.95. Epub 2004 Aug 30. Circulation. 2004. PMID: 15337694
625 results